Clinical Trial Update: An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating effectiveness, safety and quality of life with hydromorphone hydrochloride extended-release (Dilaudid CR) in knee and hip osteoarthriti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• Dilaudid CR (hydromorphone hydrochloride)

Snippet

Sponsor: Alza Corporation, DE, USA | Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip | Phase 3 | Status: COMPLETED